ESGE 2015 (Budapest)
Role of Medical Treatment and Surgery for the Long-term Management of Fibroids
24th Annual Congress of European Society for Gynaecological Endoscopy. October 7th – 10th, 2015
Agenda
Selective Progesterone Receptor Modulators (SPRMs) are a new class of compounds with great potential in the treatment of Uterine Fibroids. The presentations in this scientific session discussed the potential use of Esmya® in the long term management of symptomatic Uterine Fibroids as well as its use in pre-operative setting.